An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Journal: Science Translational Medicine
Published: 2020-04-29
DOI: 10.1126/scitranslmed.abb5883
Affiliations: 10
Go to article